Hi… @Mudit.Kushalvardhan … thanks for ur kind words
I am no Peter Lynch – Obviously ( lets be fair to the great man )
WRT the depth – I do listen to and make notes of Concalls of most companies ( say – of at least 70 pc of my holdings … till I start understanding / remembering company wise business nuances ). I also read their ARs ( basically the management discussions and commentaries ). Do a little bit of scuttlebutt if the company is consumer facing. I have no special training wrt accounts ( I know the basics ). Hence, I don’t go into micro-caps where I need to go into forensic details. That’s about it
Position sizing – is important – Yes. I tend to place bigger bets ( say more than 3 pc ) and allow them to grow if the business is consumer facing or is a large cap / bigger midcaps ( it gives an emotional sense of security… In B2C – u can do a scuttlebutt. In largecaps / bigger midcaps , u can be more confident about the corporate governance. In businesses / sectors with high complexity – like Pharma ( CDMOs, Complex generics makers etc ), I tend to diversify as its impossible for me to know about all the business nuances ( beyond a point )
Increased number of stocks in my portfolio is a recent phenomenon ( last 3-4 yrs ). The more I read, the more tempted I am to buy more businesses. Plus – greater reading also makes one realise the futility of being too confident – unless one is specially talented / ready to go to greater depth
For someone who aims to do a CAGR of > 25 pc or so ( I know a lot of ppl who do it regularly ), the only option ( IMHO ) is to go in with a concentrated portfolio with greater depth of knowledge about each company
Regards
Ranvir Dehal
Subscribe To Our Free Newsletter |